Giving hope to people worldwide, Hyderabad based company Bharat Biotech on Monday announced that it’s COVAXIN has become the country’s first covid vaccine. Considering the continuous rise in coronavirus cases, many companies have been working over it.
COVAXIN was tested according to schedule Y guidelines of India and World health organisation as a prior test is to be on animals. It was reported to be safe and immunogenic in all animals.
The Drug Controller General of India (DCGI), Central Drug Standard Control Organisation (CDSCO) and Ministry of health and family welfare granted permission to initiate Phase 1 and Phase 2 is human clinical trials. Phase 1 and Phase 2 of clinical trials are scheduled to start across India in July.
If it emerges successful we will have a vaccine for the deadly virus till the end of this year and we can hope for a better and prosperous upcoming year.
Certainly, many claims suggest that Ayurveda has a cure for coronavirus. But it can be seen that herbs like Tulsi, Giloy and Ashwagandha can only help you to boost your immune system but it cannot be used as an effective way to cure the virus infection. Though it helps we
cannot completely rely on Ayurveda.
India reported approx 19,000 positive cases on Tuesday, with this India’s covid -19 tally stands at 5,66,840. Death tolls to 16,893 and around 3.34 lakh people recovered.
Government of India is taking all necessary steps to ensure that we, people of India are well prepared to face the challenge.
Social distancing strategies aim to reduce contact from infected persons with a large group aid in the prevention of the diseases. It took 148 days in India to case hold covid patients to 5 lakhs.
Wearing face masks and proper sanitization also help in reducing the risk of infection. But now we all need a vaccine to overcome the pandemic.
Empowering the citizens with the right information and taking precautions as per the advisories being issued by the Ministry of Health and Family welfare. COVAXIN really comes out as a ray of hope in the darkness.